Literature DB >> 18462373

The AZF proteins.

P H Vogt1, C L Falcao, R Hanstein, J Zimmer.   

Abstract

The azoospermia factor (AZF) locus in Yq11 is now functionally subdivided in three distinct spermatogenesis loci: AZFa, AZFb and AZFc. After knowledge of the complete genomic Y sequence in Yq11, 14 Y genes encoding putatively functional proteins and expressed in human testis are found to be located in one of the three AZF intervals. Therefore, a major question for each infertility clinic performing molecular screening for AZF deletions has now raised concerning the functional contribution of the encoded AZF proteins to human spermatogenesis. Additionally, it has been shown that distinct chromatin regions in Yq11 overlapping with the genomic AZFb and AZFc intervals are probably involved in the pre-meiotic X and Y chromosome pairing process. An old hypothesis on the germ line function of AZF becomes therefore revitalized. It proposed a specific chromatin folding code in Yq11, which controls the condensation cycle of the Y chromosome in the male germ line. Thus, with the exception of AZF proteins functionally expressed during the pre-meiotic differentiation and proliferation of spermatogonia, the need for AZF proteins functionally expressed at meiosis or during the post-meiotic spermatid maturation process is difficult to assess before the identification of specific mutations in the corresponding AZF gene causing male infertility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462373     DOI: 10.1111/j.1365-2605.2008.00890.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  20 in total

1.  AZFc deletions do not affect the function of human spermatogonia in vitro.

Authors:  B Nickkholgh; C M Korver; S K M van Daalen; A M M van Pelt; S Repping
Journal:  Mol Hum Reprod       Date:  2015-04-21       Impact factor: 4.025

Review 2.  Spermatogenic failure and the Y chromosome.

Authors:  C Krausz; E Casamonti
Journal:  Hum Genet       Date:  2017-04-29       Impact factor: 4.132

3.  A biopsy sample reduction approach to identify significant alterations of the testicular transcriptome in the presence of Y-chromosomal microdeletions that are independent of germ cell composition.

Authors:  Heike Cappallo-Obermann; Kathrein von Kopylow; Wolfgang Schulze; Andrej-Nikolai Spiess
Journal:  Hum Genet       Date:  2010-07-29       Impact factor: 4.132

4.  The will-o'-the-wisp of genetics--hunting for the azoospermia factor gene.

Authors:  Chris Tyler-Smith; Csilla Krausz
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

5.  Complex transcriptional control of the AZFa gene DDX3Y in human testis.

Authors:  M-A Rauschendorf; J Zimmer; R Hanstein; C Dickemann; P H Vogt
Journal:  Int J Androl       Date:  2011-02

6.  Evaluating the relationship between spermatogenic silencing of the X chromosome and evolution of the Y chromosome in chimpanzee and human.

Authors:  Eskeatnaf Mulugeta Achame; Willy M Baarends; Joost Gribnau; J Anton Grootegoed
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

Review 7.  Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility?

Authors:  Paulo Navarro-Costa; Carlos E Plancha; João Gonçalves
Journal:  J Biomed Biotechnol       Date:  2010-06-30

Review 8.  The AZFc region of the Y chromosome: at the crossroads between genetic diversity and male infertility.

Authors:  Paulo Navarro-Costa; João Gonçalves; Carlos E Plancha
Journal:  Hum Reprod Update       Date:  2010-03-18       Impact factor: 15.610

9.  Fidgetin-like1 is a strong candidate for a dynamic impairment of male meiosis leading to reduced testis weight in mice.

Authors:  David L'Hôte; Magalie Vatin; Jana Auer; Johan Castille; Bruno Passet; Xavier Montagutelli; Catherine Serres; Daniel Vaiman
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

Review 10.  A comprehensive review of genetics and genetic testing in azoospermia.

Authors:  Alaa J Hamada; Sandro C Esteves; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.